Tony DiMeo
Head of Investor Relations
Replay available
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2025 Earnings Call
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sharad Patel
Co-Founder & Co-CEO
Shintu Patel
Co-Founder & Co-CEO
Joe Renda
Commercial Leader, Specialty
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amneal Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.859 Good morning, and welcome to the Amniel Pharmaceuticals Second Quarter 2025 Earnings 00:00:05.859 -- 00:00:12.606 Call. I will now turn the call over to Amniel's Head of Investor Relations, Tony DiMeo. 00:00:14.231 -- 00:00:19.639 Good morning, and thank you for joining Amniel Pharmaceuticals Second Quarter 2025 Earnings 00:00:19.639 -- 00:00:24.366 Call. Today, we issued a press release reporting Q2 results. 00:00:24.366 -- 00:00:29.005 The earnings press release and presentation are available at amniel.com. 00:00:29.005 -- 00:00:34.031 Certain statements made on this call regarding matters that are not historical facts, 00:00:34.031 -- 00:00:38.737 including but not limited to management's outlook or predictions, are forward-looking 00:00:38.737 -- 00:00:43.923 statements that are based solely on information that is now available to us. 00:00:43.923 -- 00:00:48.628 Please see the section entitled Cautionary Statements on Forward-Looking Statements for 00:00:48.628 -- 00:00:52.093 factors that may impact future performance. 00:00:52.093 -- 00:00:57.649 We also discussed non-GAAP measures. Information on use of these measures and reconciliations 00:00:57.649 -- 00:01:02.034 to GAAP are in the earnings release and presentation. 00:01:02.034 -- 00:01:07.521 On the call today are Sharad and Shintu Patel, co-founders and co-CEOs, 00:01:07.521 -- 00:01:13.427 Carlos Conidera, CFO, our commercial leaders, Andy Boyer for Affordable Medicines, 00:01:13.427 -- 00:01:18.133 Joe Renda for Specialty, and Jason Daly, Chief Legal Officer. 00:01:18.133 -- 00:01:20.322 I will now hand the call over to Sharad. 00:01:20.322 -- 00:01:25.688 Thank you, Tony. Good morning, everyone. The second quarter was another consecutive quarter 00:01:25.688 -- 00:...